Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease
V
V. Tabar
H
H. Sarva
A
A. M. Lozano
A
A. Fasano
S
S. K. Kalia
K
K. K. H. Yu
C
C. Brennan
Y
Y. Ma
S
S. Peng
D
D. Eidelberg
M
M. Tomishima
S
S. Irion
W
W. Stemple
N
N. Abid
A
A. Lampron
L
L. Studer
C
C. Henchcliffe
Article Details
Journal
Nature
Volume / Issue
Vol. 641, Issue 8064
Published
May 22, 2025
Pages
978-983
ISSN
0028-0836
Publisher
Nature Portfolio
Authors (17)
V
V. Tabar
H
H. Sarva
A
A. M. Lozano
A
A. Fasano
S
S. K. Kalia
K
K. K. H. Yu
C
C. Brennan
Y
Y. Ma
S
S. Peng
D
D. Eidelberg
M
M. Tomishima
S
S. Irion
W
W. Stemple
N
N. Abid
A
A. Lampron
L
L. Studer
C
C. Henchcliffe
Related Articles from this Journal
Graduating without a thesis: meet the people getting ‘practical’ PhDs in China
Xiaoying You
Jul 2026
10.1038/d41586-026-01242-z
White House rolls out AI funding — and signals a new era for US science
Dan Garisto, Kaia Glickman
Jul 2026
10.1038/d41586-026-02332-8
Personalized gene therapy relieves severe epilepsy in two boys
Jul 2026
10.1038/d41586-026-02267-0
Author Correction: Feature-specific threat coding in lateral septum guides defensive action
Dionnet Leandro Bhatti Mazo, Marc Z. C. Berger et al.
Jul 2026
10.1038/s41586-026-10911-y
Briefing Chat: Baby T. rex were killers from birth, suggest new fossils
Elizabeth Gibney, Nick Petrić Howe
Jul 2026
10.1038/d41586-026-02338-2